Ziopharm Oncology
ZIOP
#8771
Rank
NZ$0.32 B
Marketcap
NZ$1.50
Share price
-0.88%
Change (1 day)
-73.79%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -NZ$0.13 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are NZ$3.73 Million. In 2020 the company made an earning of -NZ$0.14 Billion a decrease over its 2019 earnings that were of -NZ$99.45 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.13 Billion-7.96%
2020-NZ$0.14 Billion38.89%
2019-NZ$99.45 Million7.33%
2018-NZ$92.65 Million0.77%
2017-NZ$91.94 Million-67.64%
2016-NZ$0.29 Billion37.64%
2015-NZ$0.21 Billion176.1%
2014-NZ$74.77 Million-24.63%
2013-NZ$99.2 Million-43.51%
2012-NZ$0.18 Billion43.09%
2011-NZ$0.13 Billion190.88%
2010-NZ$42.19 Million102.46%
2009-NZ$20.84 Million-52.68%
2008-NZ$44.04 Million-10.33%
2007-NZ$49.11 Million15.35%
2006-NZ$42.58 Million355.36%
2005-NZ$9.35 Million13788.35%
2004-NZ$0.07 Million9.27%
2003-NZ$0.07 Million-10.26%
2002-NZ$0.07 Million-59.35%
2001-NZ$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$15.61 B-10,279.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.88 Billion 469.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.49 B-10,850.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-NZ$4.74 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA